Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.802537
Title: Strategies for hepatitis C virus elimination, from point of care testing to investigation of a natural vaccine model
Author: Witkowska, Weronika
ISNI:       0000 0004 8510 9346
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 2020
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Thesis embargoed until 03 Mar 2023
Access from Institution:
Abstract:
Hepatitis C virus (HCV) is a major cause of chronic viral hepatitis with over 70 million people affected worldwide. Recent advances in direct acting antivirals for HCV treatment have resulted in sustained virological response rates of more than 90%. Thus, the World Health Organisation (WHO) has developed a global strategy for elimination of the virus by 2030. Major barriers to elimination include the lack of a point-of-care (POC) test for immediate linkage to care and the development of a HCV vaccine. This first part of this thesis covers experiments aimed towards the development of a novel POC test based on loop mediated isothermal amplification (LAMP). The second section of the thesis addresses the novel phenomenon of secondary spontaneous clearance (SSC), studied as a natural vaccine model to decipher the immune responses involved in spontaneous resolution following treatment relapse. A double-blind study of HCV LAMP was conducted on RNA samples of all major HCV genotypes and viral loads. The sensitivity and specificity of the assay was 90% and 98%, respectively within less than 25 minutes of incubation which fulfils current WHO recommendations. We developed a user-friendly read-out based on a pregnancy-test like lateral flow device. LAMP has minimal equipment and training requirements with previous field studies making it ideal for a future HCV POC test. The two cases of SSC post-treatment relapse were studied in comparison with four treatment failure (TF) patients. In both SSC cases, low levels of neutralising antibody were detected at the time of diagnosis but on relapse, a robust and sustained response was generated that reduced the infectivity of autologous viral pseudoparticles expressing HCV envelope proteins – a feature not present in any control patients. Furthermore, significant differences in levels of Th-1 cytokines were noted prior to treatment in SSC but not TF. This natural vaccine model (prime on acute infection, boost on relapse) adds weight to the importance of adaptive immune responses in resolving HCV infection.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.802537  DOI: Not available
Keywords: QR180 Immunology ; QR355 Virology
Share: